These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14606217)

  • 1. Pharmacologic therapies aid treatment for autism.
    Lindsay RL; Aman MG
    Pediatr Ann; 2003 Oct; 32(10):671-6. PubMed ID: 14606217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychopharmacology of autistic disorders].
    Poustka L; Poustka F
    Z Kinder Jugendpsychiatr Psychother; 2007 Mar; 35(2):87-94. PubMed ID: 17608278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.
    Arnold LE; Gadow KD; Farmer CA; Findling RL; Bukstein O; Molina BS; Brown NV; Li X; Rundberg-Rivera EV; Bangalore S; Buchan-Page K; Hurt EA; Rice R; McNamara NK; Aman MG
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):203-12. PubMed ID: 25885010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotics for behavioral problems in children.
    Shafiq S; Pringsheim T
    Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
    Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
    J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M
    Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Antipsychotic Drugs for Disruptive Behaviour Disorders in Children and Youths.
    Noyce G
    Issues Ment Health Nurs; 2019 Feb; 40(2):185-186. PubMed ID: 30620631
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ.
    Aman M; Buitelaar J; Smedt GD; Wapenaar R; Binder C
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):220-32. PubMed ID: 15910206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
    Correll CU; Kratochvil CJ; March JS
    J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
    McDougle CJ; Scahill L; Aman MG; McCracken JT; Tierney E; Davies M; Arnold LE; Posey DJ; Martin A; Ghuman JK; Shah B; Chuang SZ; Swiezy NB; Gonzalez NM; Hollway J; Koenig K; McGough JJ; Ritz L; Vitiello B
    Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone in the management of disruptive behavior disorders.
    Pandina GJ; Aman MG; Findling RL
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):379-92. PubMed ID: 16958564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
    Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
    Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors.
    Beherec L; Lambrey S; Quilici G; Rosier A; Falissard B; Guillin O
    J Clin Psychopharmacol; 2011 Jun; 31(3):341-4. PubMed ID: 21508854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics in disruptive behavior disorders and ADHD.
    Keenan K
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):969-70; author reply 970-1. PubMed ID: 16175099
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of functional analysis methodology in the evaluation of medication effects.
    Crosland KA; Zarcone JR; Lindauer SE; Valdovinos MG; Zarcone TJ; Hellings JA; Schroeder SR
    J Autism Dev Disord; 2003 Jun; 33(3):271-9. PubMed ID: 12908830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.